For the quarter ending 2025-09-30, SNSE has $27,589K in assets. $4,582K in debts. $10,562K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 10,562 | 12,557 | ||
| Marketable securities | 14,479 | 16,071 | ||
| Prepaid expenses | 496 | 828 | ||
| Other current assets | 248 | 116 | ||
| Total current assets | 25,785 | 29,572 | ||
| Right of use assets - operating leases, net | 1,668 | 2,034 | ||
| Right of use assets - financing leases, net | 6 | 10 | ||
| Total property and equipment | 622 | - | ||
| Less accumulated depreciation and amortization | 510 | - | ||
| Property and equipment, net | 112 | 143 | ||
| Other non-current assets | 18 | 24 | ||
| Total assets | 27,589 | 31,783 | ||
| Accounts payable and accrued liabilities | 1,405 | 1,135 | ||
| Compensation and employee benefits liabilities | 1,156 | 775 | ||
| Operating lease liabilities, current | 1,682 | 1,622 | ||
| Financing lease liabilities, current | 193 | 341 | ||
| Total current liabilities | 4,436 | 3,873 | ||
| Operating lease liabilities, non-current | 146 | 592 | ||
| Financing lease liabilities, non-current | 0 | 4 | ||
| Total liabilities | 4,582 | 4,469 | ||
| Additional paid-in capital | 301,431 | 301,177 | ||
| Accumulated deficit | -278,421 | -273,852 | ||
| Accumulated other comprehensive loss | -3 | -11 | ||
| Total stockholders' equity | 23,007 | 27,314 | ||
| Total liabilities and stockholders' equity | 27,589 | 31,783 | ||
Sensei Biotherapeutics, Inc. (SNSE)
Sensei Biotherapeutics, Inc. (SNSE)